Patience, it can take some time to determine the best way to tell everyone that paying Pfizer's attorney fees will bankrupt the company without a significant ATM.
Interesting observation. However, unless they are very close to finalizing the deal, it's hard to see why they would delay the quarterly release and earnings call for it.
They could simply release the earnings first and schedule a separate call once the partnership is officially announced.
I suppose we'll find out in the coming days. Hoping for a nice suprise here.
Market Data 
Markets 
AI
